Masashi Takano Selected Research

Irinotecan (Camptosar)

1/2018	Efficacy of combination chemotherapy using irinotecan and nedaplatin for patients with recurrent and refractory endometrial carcinomas: preliminary analysis and literature review.
7/2017	Combination of irinotecan and platinum for platinum-resistant or refractory recurrent ovarian cancers: A preliminary case series.
1/2017	UGT1A1 polymorphisms in cancer: impact on irinotecan treatment.
6/2016	Impact of UGT1A1 genotype upon toxicities of combination with low-dose irinotecan plus platinum.
6/2012	Clear cell carcinoma of the ovary: is there a role of histology-specific treatment?
4/2010	Indispensability of UGT1A1*6 genotyping in Japanese cancer patients treated with irinotecan.
2/2010	Randomized phase II trial of paclitaxel plus carboplatin therapy versus irinotecan plus cisplatin therapy as first-line chemotherapy for clear cell adenocarcinoma of the ovary: a JGOG study.
1/2009	Clinical significance of UDP-glucuronosyltransferase 1A1*6 for toxicities of combination chemotherapy with irinotecan and cisplatin in gynecologic cancers: a prospective multi-institutional study.
8/2007	Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin: retrospective analysis.
12/2006	Adjuvant chemotherapy with irinotecan hydrochloride and cisplatin for clear cell carcinoma of the ovary.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masashi Takano Research Topics

Disease

71	Neoplasms (Cancer) 03/2024 - 02/2002
36	Carcinoma (Carcinomatosis) 12/2022 - 03/2004
29	Ovarian Neoplasms (Ovarian Cancer) 08/2021 - 05/2002
15	Endometrial Neoplasms (Endometrial Cancer) 03/2023 - 03/2010
11	Ovarian Epithelial Carcinoma 09/2021 - 05/2002
11	Neoplasm Metastasis (Metastasis) 12/2019 - 12/2007
9	Hemorrhage 01/2024 - 12/2004
9	Placenta Previa 06/2023 - 01/2016
9	Hypercalcemia (Milk Alkali Syndrome) 01/2016 - 07/2006
9	Clear Cell Adenocarcinoma 06/2012 - 02/2008
7	Endometriosis 05/2020 - 02/2008
6	Adenocarcinoma 01/2021 - 02/2002
6	Breast Neoplasms (Breast Cancer) 07/2018 - 12/2008
6	Osteosarcoma (Osteogenic Sarcoma) 01/2018 - 01/2012
5	Ascites 09/2023 - 07/2009
5	Osteoporosis 10/2018 - 07/2006
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2016 - 01/2003
4	Rickets (Rachitis) 01/2022 - 10/2015
3	Postpartum Hemorrhage 11/2021 - 08/2017
3	Disease Progression 01/2021 - 12/2004
3	Endometrioid Carcinoma 10/2020 - 01/2018
3	Leukemia 10/2018 - 09/2009
3	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2018 - 07/2006
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2016 - 11/2013
3	Carcinogenesis 01/2015 - 03/2010
3	Cystadenofibroma 06/2012 - 02/2008
2	Rupture 10/2018 - 08/2017
2	Varicose Veins (Varicose Vein) 10/2018 - 06/2016
2	Neutropenia 01/2018 - 05/2002
2	Uterine Rupture 12/2017 - 08/2017
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2017 - 07/2016
2	Squamous Cell Carcinoma of Head and Neck 01/2016 - 11/2013
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2014 - 04/2013
2	Liver Neoplasms (Liver Cancer) 10/2012 - 12/2011
2	Hypoxia (Hypoxemia) 05/2012 - 02/2010
1	Maxillary Sinus Neoplasms 03/2024

Drug/Important Bio-Agent (IBA)

23	hydroxide ionIBA 01/2022 - 07/2006
21	PlatinumIBA 02/2022 - 05/2002
19	Proteins (Proteins, Gene)FDA Link 12/2022 - 10/2004
17	Vitamin D FDA LinkGeneric 01/2022 - 07/2006
15	Paclitaxel (Taxol)FDA LinkGeneric 03/2024 - 05/2002
14	19- nor- 2- (3- hydroxypropyl)- 1,25- dihydroxyvitamin D3IBA 07/2018 - 12/2011
13	Carboplatin (JM8)FDA LinkGeneric 03/2024 - 10/2004
13	Biomarkers (Surrogate Marker)IBA 11/2021 - 02/2010
13	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 05/2002
11	Irinotecan (Camptosar)FDA LinkGeneric 01/2018 - 01/2003
9	Bevacizumab (Avastin)FDA Link 02/2022 - 11/2008
7	OsteocalcinIBA 01/2018 - 09/2009
6	Calcitriol Receptors (Calcitriol Receptor)IBA 10/2018 - 09/2009
5	LigandsIBA 12/2022 - 02/2008
5	taxaneIBA 10/2019 - 07/2009
5	Indicators and Reagents (Reagents)IBA 01/2018 - 12/2004
5	Therapeutic UsesIBA 01/2018 - 11/2011
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 11/2008
4	Gemcitabine FDA Link 01/2020 - 02/2013
4	Cholecalciferol (Vitamin D3)FDA Link 11/2016 - 10/2012
3	pembrolizumabIBA 01/2023 - 01/2021
3	lenvatinibIBA 01/2023 - 01/2021
3	CA-125 Antigen (CA 125 Antigen)IBA 04/2021 - 08/2010
3	liposomal doxorubicin (Doxil)FDA Link 01/2021 - 08/2011
3	VimentinIBA 09/2020 - 07/2010
3	Estrogen ReceptorsIBA 07/2018 - 01/2012
3	nedaplatinIBA 01/2018 - 01/2003
2	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2022
2	Formaldehyde (Formol)FDA Link 04/2022 - 02/2010
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
2	polysulfideIBA 08/2021 - 01/2021
2	MesothelinIBA 04/2021 - 10/2020
2	1-dodecylpyridoxal (PLD)IBA 01/2021 - 08/2011
2	Amino Acid Transport Systems (Amino Acid Transporter)IBA 09/2020 - 06/2019
2	CalciumIBA 01/2018 - 07/2006
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2018 - 05/2002
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2018 - 12/2006
2	MineralsIBA 01/2017 - 01/2016
2	Hemostatics (Antihemorrhagics)IBA 01/2017 - 01/2016
2	Cytotoxins (Cytolysins)IBA 06/2013 - 04/2013
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2013 - 02/2013
2	ActininIBA 06/2012 - 12/2007
2	DNA (Deoxyribonucleic Acid)IBA 04/2012 - 10/2011
2	Cyclin AIBA 05/2010 - 11/2009
2	Cyclin EIBA 05/2010 - 11/2009
2	Complementary DNA (cDNA)IBA 10/2007 - 05/2006
1	Cetuximab (Erbitux)FDA Link 03/2024

Therapy/Procedure

37	Drug Therapy (Chemotherapy) 10/2023 - 05/2002
27	Therapeutics 01/2023 - 05/2005
12	Cesarean Section (Caesarean Section) 06/2023 - 01/2016
9	Hysterectomy 01/2024 - 12/2004
6	Combination Drug Therapy (Combination Chemotherapy) 01/2018 - 01/2003
4	Salpingo-oophorectomy 01/2024 - 06/2015
4	Neoadjuvant Therapy 03/2023 - 07/2009
4	Radiotherapy 01/2021 - 01/2012
3	Lymph Node Excision (Lymph Node Dissection) 09/2023 - 11/2011
3	Adjuvant Chemotherapy 12/2010 - 12/2006
2	Immunotherapy 01/2023 - 01/2022
2	Catheters 10/2018 - 06/2016
2	Uterine Artery Embolization 08/2018 - 08/2017
2	Operative Surgical Procedures 11/2012 - 05/2008
2	Palliative Care (Palliative Therapy) 11/2012 - 10/2009
2	Cytoreduction Surgical Procedures 02/2011 - 07/2009
1	Induction Chemotherapy 03/2024